Prevalence of risk factors in men with premature coronary artery disease

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge

Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · see citing works

The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in Incidence of Coronary Heart Disease

(1984) · JAMA · doi:10.1001/jama.1984.03340270029025 · Cited by 2,747 · see citing works

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

Goodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,292 · see citing works

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824 · see citing works

Clofibrate and Niacin in Coronary Heart Disease

Stamler, J. (1975) · JAMA · doi:10.1001/jama.1975.03240160024021 · Cited by 1,750 · see citing works

Multiple Risk Factor Intervention Trial

Michel, D. (1982) · JAMA · doi:10.1001/jama.1982.03330120023025 · Cited by 1,731 · see citing works

Quantitative Effects of Dietary Fat on Serum Cholesterol in Man

Hegsted, D. M., McGandy, R. B., Myers, M. L., & Stare, F. J. (1965) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/17.5.281 · Cited by 1,589 · see citing works

High-Density Lipoprotein — The Clinical Implications of Recent Studies

Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547 · see citing works

The Lipid Research Clinics Coronary Primary Prevention Trial Results

(1984) · JAMA · doi:10.1001/jama.1984.03340270043026 · Cited by 1,402 · see citing works

Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?: Findings in 356 222 Primary Screenees of the Multiple Risk Factor Intervention Trial (MRFIT)

Stamler, J. (1986) · JAMA · doi:10.1001/jama.1986.03380200061022 · Cited by 1,318 · see citing works

SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN

Martin, M., Browner, W. S., Hulley, S. B., Kuller, L., & Wentworth, D. N. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90597-0 · Cited by 1,117 · see citing works

Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study

Manninen, V. (1988) · JAMA · doi:10.1001/jama.1988.03410050061031 · Cited by 954 · see citing works

HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia

Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 760 · see citing works

Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic Acid

Carlson, L. A., & Rosenhamer, G. (1988) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb15891.x · Cited by 685 · see citing works

Validation of a semi-quantitative food frequency questionnaire: Comparison with a 1-year diet record

Willett, W. C., Reynolds, R. D., Cottrell-Hoehner, S., Sampson, L., & Browne, M. L. (1987) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)03057-1 · Cited by 545 · see citing works

Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions

McNamara, J. R., & Schaefer, E. J. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90188-4 · Cited by 524 · see citing works

High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study.

Abbott, R. D., Wilson, P. W. F., Kannel, W. B., & Castelli, W. P. (1988) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.8.3.207 · Cited by 436 · see citing works

Strategies for the prevention of coronary heart disease: A policy statement of the European Atherosclerosis Society

STUDY GROUP, E. A. S. (1987) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a062165 · Cited by 231 · see citing works

β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction

Koch‐Weser, J., Frishman, W. H., Furberg, C. D., & Friedewald, W. T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403293101306 · Cited by 211 · see citing works

Fibric acids: Effects on lipids and lipoprotein metabolism

Grundy, S. M., & Vega, G. L. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90866-7 · Cited by 177 · see citing works

The Prevalence of High Blood Cholesterol Levels Among Adults in the United States

Sempos, C. T. (1989) · JAMA · doi:10.1001/jama.1989.03430010057031 · Cited by 159 · see citing works

Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease

Miller, M. J., Mead, L. A., Kwiterovich, P. O., & Pearson, T. A. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90017-u · Cited by 104 · see citing works

Impact of national guidelines for cholesterol risk factor screening. The Framingham Offspring Study

Wilson, P. W. F. (1989) · JAMA · doi:10.1001/jama.262.1.41 · Cited by 96 · see citing works

The effects of beta‐adrenergic blocking agents on blood lipid levels

Wolinsky, H. (1987) · Clinical Cardiology · doi:10.1002/clc.4960101010 · Cited by 41 · see citing works

Effect of hospitalization on high-density lipoprotein cholesterol in patients undergoing elective coronary angiography

Genest, J. J., Corbett, H. M., McNamara, J. R., Schaefer, M. M., Salem, D. N., & Schaefer, E. J. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90114-2 · Cited by 29 · see citing works

Effect of elective hospitalization on plasma lipoprotein cholesterol and apolipoproteins A-I, B and Lp(a)

Genest, J. J., McNamara, J. R., Ordovás, J. M., Martin-Munley, S., Jenner, J. L., Millar, J. S., Salem, D. N., & Schaefer, E. J. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91052-8 · Cited by 26 · see citing works

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439 · see citing works

Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol

Brousseau, M. E., Schaefer, E. J., Wolfe, M. L., Bloedon, L. T., Digenio, A. G., Clark, R. W., Mancuso, J. P., & Rader, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031766 · Cited by 774 · see citing works

High Density Lipoproteins and Arteriosclerosis

von Eckardstein, A., Nofer, J., & Assmann, G. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 696 · see citing works

Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.

Carr, M. C., & Brunzell, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0432 · Cited by 493 · see citing works

HDL as a target in the treatment of atherosclerotic cardiovascular disease

Linsel‐Nitschke, P., & Tall, A. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1658 · Cited by 482 · see citing works

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

Barter, P. J., Ballantyne, C. M., Carmena, R., Cabezas, M. C., Chapman, M. J., Couture, P., Graaf, J. D., Durrington, P. N., Færgeman, O., Frohlich, J., et al. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01616.x · Cited by 463 · see citing works

Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges

Sampson, U. K., Fazio, S., & Linton, M. F. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0219-7 · Cited by 439 · see citing works

Lipoproteins, nutrition, and heart disease.

Schaefer, E. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.2.191 · Cited by 448 · see citing works

ABC1 Gene Expression and ApoA-I-Mediated Cholesterol Efflux Are Regulated by LXR

Schwartz, K., Lawn, R. M., & Wade, D. P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3243 · Cited by 410 · see citing works

HDL Function, Dysfunction, and Reverse Cholesterol Transport

Fisher, E., Feig, J. E., Hewing, B., Hazen, S., & Smith, J. D. (2012) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300133 · Cited by 375 · see citing works

High-density lipoproteins: A consensus statement from the National Lipid Association

Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336 · see citing works

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

Chapman, M. J., Le Goff, W., Guerin, M., & Kontush, A. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp399 · Cited by 298 · see citing works

HDL cholesterol: reappraisal of its clinical relevance

März, W., Kleber, M. E., Scharnagl, H., Speer, T., Zewinger, S., Ritsch, A., Parhofer, K. G., von Eckardstein, A., Landmesser, U., & Laufs, U. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1106-1 · Cited by 275 · see citing works

Homozygous Tangier disease and cardiovascular disease

Serfaty-Lacrosnière, C., Civeira, F., Lanzberg, A., Isaia, P., Berg, J., Janus, E. D., Smith, M. P., Pritchard, P. H., Frohlich, J., Lees, R. S., et al. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90144-9 · Cited by 261 · see citing works

Comparison of Various Electrophoretic Characteristics of LDL Particles and Their Relationship to the Risk of Ischemic Heart Disease

St-Pierre, A., Ruel, I. L., Cantin, B., Dagenais, G. R., Bernard, P., Després, J., & Lamarche, B. (2001) · Circulation · doi:10.1161/hc4401.098490 · Cited by 259 · see citing works

Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.

Schaefer, E. J., Lamon‐Fava, S., Cohn, S. D., Schaefer, M. M., Ordovás, J. M., Castelli, W. P., & Wilson, P. W. F. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39173-2 · Cited by 259 · see citing works

Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid – a position paper developed by the European Consensus Panel on HDL-C*

Chapman, M. J., Assmann, G., Fruchart, J., Shepherd, J., & Sirtori, C. R. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125004402 · Cited by 255 · see citing works

Efficacy and safety of an extended-release niacin (Niaspan): a long-term study

Capuzzi, D. M., Guyton, J. R., Morgan, J. M., Goldberg, A. C., Kreisberg, R. A., Brusco, O. A., & Brody, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00731-0 · Cited by 254 · see citing works

Distribution of lipids in 8,500 men with coronary artery disease

Bloomfield, H. E., Robins, S. J., Collins, D. E., Iranmanesh, A., Wilt, T. J., Mann, D. L., Mayo‐Smith, M. F., Faas, F. H., Elam, M. B., Rutan, G. H., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80761-9 · Cited by 238 · see citing works

LXR-Induced Redistribution of ABCG1 to Plasma Membrane in Macrophages Enhances Cholesterol Mass Efflux to HDL

Wang, N., Ranalletta, M., Matsuura, F., Peng, F., & Tall, A. R. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000218998.75963.02 · Cited by 220 · see citing works

Molecular mechanisms of vascular effects of High‐density lipoprotein: alterations in cardiovascular disease

Besler, C., Lüscher, T. F., & Landmesser, U. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200224 · Cited by 219 · see citing works

PPARα in atherosclerosis and inflammation

Zandbergen, F. J., & Plutzky, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.021 · Cited by 215 · see citing works

A Reexamination of Smoking Before, During, and After Pregnancy

Kahn, R. S., Certain, L., & Whitaker, R. C. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.11.1801 · Cited by 216 · see citing works

Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study.

Schaefer, E. J., Lamon‐Fava, S., Ordovás, J. M., Cohn, S. D., Schaefer, M. M., Castelli, W. P., & Wilson, P. W. F. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39181-1 · Cited by 200 · see citing works

Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Que´bec cardiovascular study)

Lamarche, B., Després, J., Moorjani, S., Cantin, B., Dagenais, G. R., & Lupien, P.-J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80760-7 · Cited by 170 · see citing works

Ineffective Secondary Prevention in Survivors of Cardiovascular Events in the US Population

Qureshi, A. I., Suri, M. F. K., Guterman, L. R., & Hopkins, L. N. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1621 · Cited by 149 · see citing works

Changes in plasma antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption

Ruel, G., Pomerleau, S., Couture, P., Lamarche, B., & Couillard, C. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.031 · Cited by 148 · see citing works

Fibrates, dyslipoproteinaemia and cardiovascular disease

Watts, G. F., & Dimmitt, S. B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199912000-00011 · Cited by 145 · see citing works

Cholesterol measures to identify and treat individuals at risk for coronary heart disease

Natarajan, S., Glick, H. A., Criqui, M. H., Horowitz, D., Lipsitz, S. R., & Kinosian, B. P. (2003) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(03)00092-8 · Cited by 141 · see citing works

ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia

Guay, S., Brisson, D., Munger, J., Lamarche, B., Gaudet, D., & Bouchard, L. (2012) · Epigenetics · doi:10.4161/epi.19633 · Cited by 135 · see citing works

A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice

Jahagirdar, R., Zhang, H., Azhar, S., Tobin, J., Attwell, S., Yu, R., Wu, J., McLure, K. G., Hansen, H. C., Wagner, G. S., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.06.008 · Cited by 134 · see citing works

Newer perspectives of coronary artery disease in young

Aggarwal, A., Srivastava, S., & Velmurugan, M. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i12.728 · Cited by 135 · see citing works

Triglycerides and HDL Cholesterol

Bitzur, R., Cohen, H., Kamari, Y., Shaish, A., & Harats, D. (2009) · Diabetes Care · doi:10.2337/dc09-s343 · Cited by 132 · see citing works

Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease

Franceschini, G. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02146-4 · Cited by 130 · see citing works

Targeting Low HDL-Cholesterol to Decrease Residual Cardiovascular Risk in the Managed Care Setting

Cziraky, M. J., Watson, K. E., & Talbert, R. L. (2008) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2008.14.s8-a.1 · Cited by 132 · see citing works

Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study

Lamarche, B., Després, J., Moorjani, S., Cantin, B., Dagenais, G. R., & Lupien, P.-J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05653-x · Cited by 129 · see citing works

Clustering of cardiovascular risk factors: Targeting high-risk individuals

Genest, J. J., & Cohn, J. S. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80010-4 · Cited by 121 · see citing works

Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids

Aouizerat, B. E., Kulkarni, M. V., Heilbron, D. C., Drown, D. J., Raskin, S., Pullinger, C. R., Malloy, M. J., & Kane, J. P. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200480-jlr200 · Cited by 118 · see citing works

Obesity‐related Changes in High‐density Lipoprotein Metabolism

Mooradian, A. D., Haas, M. J., Wehmeier, K. R., & Wong, N. C. W. (2008) · Obesity · doi:10.1038/oby.2008.202 · Cited by 115 · see citing works

The physiology of lipoproteins

Tulenko, T. N., & Sumner, A. E. (2002) · Journal of Nuclear Cardiology · doi:10.1067/mnc.2002.128959 · Cited by 113 · see citing works

Trans-fatty acid patterns in patients with angiographically documented coronary artery disease

Siguel, E. N., & Lerman, R. H. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90906-s · Cited by 114 · see citing works

Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease

Srivastava, R. A. K. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3165-z · Cited by 111 · see citing works

The Treatment Gap in Coronary Artery Disease and Heart Failure: Community Standards and the Post-Discharge Patient

Pearson, T. A., & Peters, T. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00820-5 · Cited by 109 · see citing works

Postprandial inflammation and endothelial dysfuction

Alipour, A., Elte, J. W. F., van Zaanen, H. C. T., Rietveld, A. P., & Cabezas, M. C. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350466 · Cited by 108 · see citing works

Comparative effects of lipid-lowering therapies

Davidson, M. H., & Toth, P. P. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2004.04.007 · Cited by 103 · see citing works

Dual Mechanisms of ABCA1 Regulation by Geranylgeranyl Pyrophosphate

Gan, X., Kaplan, R. A., Menke, J. G., MacNaul, K. L., Chen, Y., Sparrow, C. P., Zhou, G., Wright, S. D., & Cai, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109402200 · Cited by 101 · see citing works

Predominance of Large LDL and Reduced HDL 2 Cholesterol in Normolipidemic Men With Coronary Artery Disease

Campos, H., Roederer, G. O., Lussier‐Cacan, S., Davignon, J., & Krauss, R. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1043 · Cited by 101 · see citing works

Rationale and design of the Department of Veterans Affairs high-density lipoprotein cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol

Bloomfield, H. E., Robins, S. J., Iwane, M. K., Boden, W. E., Elam, M. B., Fye, C. L., Gordon, D. J., Schaefer, E. J., Schectman, G., & Wittes, J. T. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90708-k · Cited by 99 · see citing works

Has the association between saturated fatty acids, serum cholesterol and coronary heart disease been over emphasized?

Parodi, P. W. (2009) · International Dairy Journal · doi:10.1016/j.idairyj.2009.01.001 · Cited by 98 · see citing works

Lipid transfer proteins (LTP) and atherosclerosis

Stein, O. T., & Stein, Y. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.10.008 · Cited by 95 · see citing works

Cellular Cholesterol Transport and Efflux in Fibroblasts Are Abnormal in Subjects With Familial HDL Deficiency

Marcil, M., Yu, L., Krimbou, L., Boucher, B., Oram, J. F., Cohn, J. S., & Genest, J. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.159 · Cited by 89 · see citing works

Premature myocardial infarction: Clinical profile and angiographic findings

Pineda, J., Marín, F. R., Roldán, V., Valencia, J., Marco, P., & Sogorb, F. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.02.038 · Cited by 88 · see citing works

A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy

Aguíar, C., Alegría, E., Bonadonna, R. C., Catapano, A. L., Cosentino, F., Elisaf, M., Farnier, M., Ferrières, J., Filardi, P. P., Hâncu, N., et al. (2015) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(15)30001-5 · Cited by 84 · see citing works

Clustering of Risk Factors for Coronary Heart Disease The Longitudinal Relationship with Lifestyle

Twisk, J. W. R. (2001) · Annals of Epidemiology · doi:10.1016/s1047-2797(00)00202-7 · Cited by 84 · see citing works

A Common Mutation of the Insulin Receptor Substrate-1 Gene Is A Risk Factor for Coronary Artery Disease

Baroni, M. G., D’Andrea, M. P., Montali, A., Pannitteri, G., Barillà, F., Campagna, F., Mazzei, E. M. E., Lovari, S., Seccareccia, F., Campa, P. P., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.12.2975 · Cited by 83 · see citing works

Acute myocardial infarction in young adults: Prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-term follow-up

Brscic, E., Bergerone, S., Gagnor, A., Colajanni, E., Matullo, G., Scaglione, L., Cassader, M., Gaschino, G., Leo, M. D., Brusca, A., et al. (2000) · American Heart Journal · doi:10.1067/mhj.2000.106165 · Cited by 80 · see citing works

High Density Lipoproteins in Health and in Disease

Genest, J. J., Marcil, M., Denis, M., & Yu, L. (1999) · Journal of Investigative Medicine · doi:10.1177/108155899904700106 · Cited by 80 · see citing works

Low HDL-C: A secondary target of dyslipidemia therapy

Rosenson, R. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.021 · Cited by 78 · see citing works

PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS: How Their Effects on Macrophages Can Lead to the Development of a New Drug Therapy Against Atherosclerosis

Li, A. C., & Palinski, W. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141247 · Cited by 77 · see citing works

Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations

Mott, S., Yu, L., Marcil, M., Boucher, B., Rondeau, C., & Genest, J. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00498-0 · Cited by 77 · see citing works

Diurnal triglyceride profiles: a novel approach to study triglyceride changes

Cabezas, M. C., Halkes, C. J. M., Meijssen, S., van Oostrom, A. J. H. H. M., & Erkelens, D. W. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00554-2 · Cited by 75 · see citing works

Low High-Density Lipoprotein Cholesterol

Hersberger, M., & von Eckardstein, A. (2003) · Drugs · doi:10.2165/00003495-200363180-00003 · Cited by 74 · see citing works

Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease

Koba, S., Hirano, T., Kondo, T., Shibata, M., Suzuki, H., Murakami, M., Geshi, E., & Katagiri, T. (2002) · American Heart Journal · doi:10.1067/mhj.2002.126119 · Cited by 73 · see citing works

Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease

Peloso, G. M., Demissie, S., Collins, D. E., Mirel, D. B., Gabriel, S., Cupples, L. A., Robins, S. J., Schaefer, E. J., & Brousseau, M. E. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p008268 · Cited by 71 · see citing works

Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes

Koba, S., Hirano, T., Yoshino, G., Sakai, K., Sakaue, T., Adachi, M., & Katagiri, T. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00580-9 · Cited by 69 · see citing works

Familial lipoprotein disorders and premature coronary artery disease

Schaefer, E. J., Genest, J. J., Ordovás, J. M., Salem, D. N., & Wilson, P. W. F. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90152-x · Cited by 68 · see citing works

Lipaemia, Inflammation and Atherosclerosis

van Oostrom, A. J. H. H. M., van Wijk, J. P. H., & Cabezas, M. C. (2004) · Drugs · doi:10.2165/00003495-200464002-00004 · Cited by 67 · see citing works

Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent data

Fredenrich, A., & Bayer, P. M. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70029-0 · Cited by 65 · see citing works

Altered fatty acid metabolism in patients with angiographically documented coronary artery disease

Siguel, E. N., & Lerman, R. H. (1994) · Metabolism · doi:10.1016/0026-0495(94)90178-3 · Cited by 64 · see citing works

LDL‐C/HDL‐C ratio in subjects with cardiovascular disease and a low HDL‐C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study

Jukema, J. W., Liem, A. H., Dunselman, P. H. J. M., van der Sloot, J. A. P., Lok, D. J. A., & Zwinderman, A. H. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x74952 · Cited by 61 · see citing works

Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport

Lesná, I. K., Suchánek, P., Kovář, J., Stávek, P., & Poledne, R. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800271-jlr200 · Cited by 60 · see citing works

Compound heterozygosity at the sphingomyelin phosphodiesterase-1 (SMPD1) gene is associated with low HDL cholesterol

Lee, C. Y., Krimbou, L., Vincent, J., Bernard, C., Larramée, P., Genest, J. J., & Marcil, M. (2003) · Human Genetics · doi:10.1007/s00439-002-0893-1 · Cited by 54 · see citing works

Diurnal triglyceride profiles in healthy normolipidemic male subjects are associated to insulin sensitivity, body composition and diet

van Oostrom, A. J. H. H. M., Cabezas, M. C., Ribalta, J., Masana, L., Twickler, T. B., Remijnse, T. A. W., & Erkelens, D. W. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00732.x · Cited by 56 · see citing works

CETP inhibition in cardiovascular risk management: a critical appraisal

Dullaart, R. P. F., Dallinga‐Thie, G. M., Wolffenbuttel, B. H. R., & van Tol, A. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01756.x · Cited by 54 · see citing works

Incorporation of lean red meat into a National Cholesterol Education Program Step I diet: a long-term, randomized clinical trial in free-living persons with hypercholesterolemia.

Hunninghake, D. B., Maki, K. C., Kwiterovich, P. O., Davidson, M. H., Dicklin, M. R., & Kafonek, S. D. (2000) · Journal of the American College of Nutrition · doi:10.1080/07315724.2000.10718931 · Cited by 52 · see citing works

Common Variation in the CETP Gene and the Implications for Cardiovascular Disease and its Treatment: An Updated Analysis

Dullaart, R. P. F., & Sluiter, W. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.6.747 · Cited by 52 · see citing works

Bacterial lipopolysaccharide induces expression of ABCA1 but not ABCG1 via an LXR-independent pathway

Kaplan, R. A., Gan, X., Menke, J. G., Wright, S. D., & Cai, T. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30470-3 · Cited by 51 · see citing works

LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention

Sirtori, C. R., & Fumagalli, R. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.024 · Cited by 51 · see citing works

Effect of Serum Lipids, Lipoproteins, and Apolipoproteins on Vascular and Nonvascular Mortality in the Elderly

Räihä, I. J., Marniemi, J., Puukka, P. J., Toikka, T., Ehnholm, C., & Sourander, L. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.7.1224 · Cited by 51 · see citing works

Epigenome-Wide Analysis in Familial Hypercholesterolemia Identified New Loci Associated with High-Density Lipoprotein Cholesterol Concentration

Guay, S., Voisin, G., Brisson, D., Munger, J., Lamarche, B., Gaudet, D., & Bouchard, L. (2012) · Epigenomics · doi:10.2217/epi.12.62 · Cited by 50 · see citing works

Serum Lipid Concentrations and Prevalence of Dyslipidemia in a Large Professional Population in Beijing

Li, Z., Yang, R., Xu, G., & Xia, T. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038646 · Cited by 51 · see citing works

Low high-density lipoprotein cholesterol and cardiovascular disease: Risk reduction with statin therapy

Rosenson, R. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.049 · Cited by 49 · see citing works

Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol

Bersot, T. P., Pépin, G. M., & Mahley, R. W. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00516-7 · Cited by 44 · see citing works

Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL‐cholesterol levels: a 12‐week randomized trial

Despres, J., Lemieux, I., Salomon, H., & Delaval, D. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00988.x · Cited by 49 · see citing works

Cardiovascular Death in Dialysis Patients

Sniderman, A. D., Solhpour, A., Alam, A., Williams, K., & Sloand, J. A. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06300909 · Cited by 43 · see citing works

Importancia del colesterol HDL en la aterotrombosis. ¿De dónde venimos? ¿Hacia dónde vamos?

Badimón, J. J., Santos‐Gallego, C. G., & Badimón, L. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70150-0 · Cited by 43 · see citing works

Clinical features, management and in-hospital outcome of ST elevation myocardial infarction (STEMI) in young adults under 40 years of age

Hosseini, S. K., Soleimani, A., Karimi, A., Sadeghian, S., Darabian, S., Abbasi, S. H., Ahmadi, S. H., Zoroufian, A., Mahmoodian, M., & Abbasi, A. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2009.331 · Cited by 42 · see citing works

Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol

Bergheanu, S. C., van Tol, A., Dallinga‐Thie, G. M., Liem, A. H., Dunselman, P. H. J. M., van der Bom, J. G., & Jukema, J. W. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x226104 · Cited by 41 · see citing works

Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator

Boffa, M. B., & Koschinsky, M. L. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0360-6 · Cited by 38 · see citing works

Apolipoprotein B as the best predictor of coronary artery disease in Iranian normolipidemic patients

Haidari, M., Moghadam, M., Chinicar, M., Ahmadieh, A., & Doosti, M. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00192-8 · Cited by 38 · see citing works

Small Dense Low-Density Lipoprotein Concentration and Oxidative Susceptibility Changes after Consumption of Soybean Oil, Rice Bran Oil, Palm Oil and Mixed Rice Bran/Palm Oil in Hypercholesterolaemic Women

Utarwuthipong, T., Komindr, S., Pakpeankitvatana, V., Songchitsomboon, S., & Thongmuang, N. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700111 · Cited by 38 · see citing works

Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia

Alagona, P. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s6714 · Cited by 37 · see citing works

Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein-deficiency states.

Santos, R. D., Asztalos, B., Martinez, L., Miname, M., Polisecki, E., & Schaefer, E. (2008) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2008.06.002 · Cited by 40 · see citing works

Novel Peroxisome Proliferator-Activated Receptor α Agonists Lower Low-Density Lipoprotein and Triglycerides, Raise High-Density Lipoprotein, and Synergistically Increase Cholesterol Excretion with a Liver X Receptor Agonist

Mukherjee, R., Locke, K. T., Miao, B., Meyers, D. S., Monshizadegan, H., Zhang, R., Search, D. J., Grimm, D., Flynn, M. A., O’Malley, K. M., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143271 · Cited by 36 · see citing works

Severe Familial HDL Deficiency in French-Canadian Kindreds

Marcil, M., Boucher, B., Krimbou, L., Solymoss, B., Davignon, J., Frohlich, J. J., & Genest, J. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1015 · Cited by 35 · see citing works

Improved lipid profile and increased serum antioxidant capacity in healthy volunteers afterSambucus ebulusL. fruit infusion consumption

Ivanova, D. G., Tasinov, O., & Kiselova-Kaneva, Y. D. (2014) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2014.898256 · Cited by 34 · see citing works

The prevention of cardiovascular disease. Emphasis on secondary prevention.

Robinson, J. C., & Leon, A. S. (1994) · The Medical clinics of North America · doi:10.1016/s0025-7125(16)30177-8 · Cited by 35 · see citing works

The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease?

Després, J. (1993) · Europe PMC (PubMed Central) · Cited by 34 · see citing works

The effects of sex, metabolic syndrome and exercise on postprandial lipemia

Cox‐York, K. A., Sharp, T. A., STOTZ, S. A., Bessesen, D. H., Pagliassotti, M. J., & Horton, T. J. (2012) · Metabolism · doi:10.1016/j.metabol.2012.08.003 · Cited by 32 · see citing works

Myocardial infarction in the young: a sex-based comparison

Sozzi, F. B., Danzi, G. B., Foco, L., Ferlini, M., Marco Tubaro, U., Galli, M., Celli, P., & Mannucci, P. M. (2007) · Coronary Artery Disease · doi:10.1097/mca.0b013e3282583bfc · Cited by 32 · see citing works

Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patients

Reibis, R. K., Treszl, Wegscheider, Bestehorn, K. P., Karmann, & Voeller, H. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s33305 · Cited by 45 · see citing works

Cardiovascular risk factors and coronary features of male patients with premature coronary artery disease

Zhou, Z.-J. (2009) · Di-san junyi daxue xuebao

Risk Factors for Coronary Artery Disease and Acute Coronary Syndrome in Patients ≤40 Years Old

Alkhawam, H., Sogomonian, R., El‐Hunjul, M., Kabach, M., Syed, U. M., Vyas, N., Ahmad, S., & Vittorio, T. J. (2016) · Future Cardiology · doi:10.2217/fca-2016-0011 · Cited by 21 · see citing works

Association of major modifiable risk factors among patients with coronary artery disease--a retrospective analysis.

Achari, V., & Thakur, A. K. (2004) · PubMed · Cited by 67 · see citing works

A Study of Risk Factors of Coronary Artery Disease and Their Association with Premature Coronary Artery Disease among Patients Attending Tertiary Care Cardiac Hospital in Pune, Maharashtra

Sampath, V., Agrawal, S. K., & Sampath, A. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3930265 · Cited by 1 · see citing works